
the podcast on
Thousands of cases of amputation and vision loss could be prevented thanks to diabetes monitoring technology.
Continuous Glucose Monitors, or CGMs, have been funded for Type 1 diabetes since last October.
New data from CGM producer Dexcom finds lifetime use of the devices could prevent up to 70 thousand diabetes-related complications and save the country $50 thousand a day.
Diabetes New Zealand Chief Executive Heather Verry told Mike Hosking funding should be expanded to all diabetes patients.
She says Pharmac is only funding for Type 1, and at $200 a month, these devices are unaffordable for everyone else.
LISTEN ABOVE
Take your Radio, Podcasts and Music with you
Get the iHeart App
Get more of the radio, music and podcasts you love with the FREE iHeart app. Scan the QR code to download now.
Download from the app stores
Stream unlimited music, thousands of radio stations and podcasts all in one app. iHeart is easy to use and all FREE
